Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
1 other identifier
interventional
25
1 country
1
Brief Summary
The aim of the study is to determine relevant hemodynamic parameters for the diagnostics of pulmonary arterial hypertension (PAH) by dynamic contrast enhanced dual-energy CT (DE-CT). In this pilot study the investigators investigate patients who underwent right heart catheterisation with DE-CT to determine hemodynamic parameters and control the results by other clinical investigations. The investigators expect that using this non-invasive method, parameters relevant for the diagnosis of the patients with PAH, like pulmonary blood volume, blood flow and perfusion heterogeneity, can be determined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 13, 2012
CompletedFirst Posted
Study publicly available on registry
May 30, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedJuly 17, 2017
July 1, 2017
5.8 years
April 13, 2012
July 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulmonary blood flow and volume determined by dual energy computed tomography
determination of differences in pulmonary blood flow and volume of pulmonary hypertension patients
measurements with right heart catheterisation within 1 month
Secondary Outcomes (2)
Comparison of dual energy computed tomography derived data with clinical findings of pulmonary hypertension patients
measurements with right heart catheterisation within 1 month
Lung perfusion heterogeneity determined by dual energy computed tomography
measurements with right heart catheterisation within 1 month
Study Arms (1)
pulmonary vascular disease
OTHERDual-energy computed tomography investigation
Interventions
1x 20ml Ultravist (370mg J/ml)3-5ml/s, 1x 70ml Ultravist (370mg J/ml)3-5ml/s Contrast agent administration
Eligibility Criteria
You may qualify if:
- patients with right heart catheterization data
You may not qualify if:
- patients with decreased renal function
- patients who received CT in the previous six months
- intolerance of contrast material
- other standard CT contraindications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Grazlead
- Ludwig Boltzmann Gesellschaftcollaborator
Study Sites (1)
Medical University Graz, Division of Pulmonology
Graz, Styria, 8010, Austria
Related Publications (3)
Helmberger M, Pienn M, Urschler M, Kullnig P, Stollberger R, Kovacs G, Olschewski A, Olschewski H, Balint Z. Quantification of tortuosity and fractal dimension of the lung vessels in pulmonary hypertension patients. PLoS One. 2014 Jan 31;9(1):e87515. doi: 10.1371/journal.pone.0087515. eCollection 2014.
PMID: 24498123RESULTPienn M, Kovacs G, Tscherner M, Avian A, Johnson TR, Kullnig P, Stollberger R, Olschewski A, Olschewski H, Balint Z. Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography: a pilot study. Eur Radiol. 2014 Mar;24(3):668-76. doi: 10.1007/s00330-013-3067-8. Epub 2013 Dec 6.
PMID: 24311231RESULTPienn M, Kovacs G, Tscherner M, Johnson TR, Kullnig P, Stollberger R, Olschewski A, Olschewski H, Balint Z. Determination of cardiac output with dynamic contrast-enhanced computed tomography. Int J Cardiovasc Imaging. 2013 Dec;29(8):1871-8. doi: 10.1007/s10554-013-0279-6. Epub 2013 Aug 23.
PMID: 23974909RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Horst Olschewski, MD
Medical University of Graz
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2012
First Posted
May 30, 2012
Study Start
June 1, 2011
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
July 17, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share